Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Consolidated Net Profit

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹260 Cr₹300 Cr₹164 Cr₹64 Cr₹81 Cr

What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?

The latest Consolidated Net Profit ratio of NEULAND LABORATORIES is ₹260 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹260 Cr
Mar2024₹300 Cr
Mar2023₹164 Cr
Mar2022₹64 Cr
Mar2021₹81 Cr

How is Consolidated Net Profit of NEULAND LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹260 Cr
-13.32
Mar2024 ₹300 Cr
83.51
Mar2023 ₹164 Cr
156.21
Mar2022 ₹64 Cr
-20.85
Mar2021 ₹81 Cr -

Compare Consolidated Net Profit of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹18,232.3 Cr -2.5% 16.4% 70.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.5%

16.4%

70.8%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses